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Cadmium Effects in Rats on Tissue Iron,
Selenium, and Blood Pressure; Blood
and Hair Cadmium in Some Oregon
Residents
by P. D. Whanger*
Exposure of rats to cadmium causes a marked depletion of iron in liver and kidney. Selenium neither
counteracts or intensifies the influence of cadmium on tissue iron levels. Selenium injections protect
against cadmium-induced testicular damage but cause this element to accumulate in the testes at higher
concentration than in animals exposed to cadmium without selenium. Selenium injection diverts the
binding ofcadmium from low molecular weight proteins to high molecular weight ones. Dosing rats with
selenium and cadmium or inclusion of Se or Cd in the diet did not result in altered cadmium binding in
tissues, raising some questions concerning the environmental significance ofthese injection experiments.
Addition ofselenium to a diet containing cadmium decreased the accumulation ofcadmium in liver and
kidney, but increased its deposition in testes. The metabolism ofcadmium bound to metaliothionein was
markedly different ascompared to the inorganic salt ofthis element. Dietary ascorbate, but not citrate or
cysteine, decreased the deposition ofcadmium in rat tissues. In some low-level exposure experiments with
cadmium (1 to 1000 ppb), no differences were found in the percentage of dose absorbed or rate of
cadmium accumulation when provided in food versus water. Female ratstended to absorb morecadmium
than males. The binding ofcadmium to cytosolic proteins was found to be different between rats fed low
levels ofcadmium (up to 1 ppm) as compared to those fed high levels ofthis element (100 ppm). Cadmium
was not found to contribute to hypertension in rats, and a summary ofresults by various investigators is
presented.
Blood and hair cadmium levels in Oregon residents were found to be highest in employees of a mine,
and hair cadmium was found to be respectively higher in smokers than nonsmokers and in metal workers
than office workers. No relationships were observed in humans between blood or haircadmium levels and
blood pressure.
Cadmium is an industrial product or by-product
which is of environmental concern. It is used in
many industrial processes, such as a constituent of
easily fusible alloys, soft solder, electroplating,
deoxidizer in nickel plating, engraving processes,
electrodes for vapor lamps, photoelectric cells, and
nickel-cadmium storage batteries (1, 2). Therefore,
there can be many industrial hazards due to this
element. Concentration of cadmium has been re-
ported to be higher in airofindustrial cities (3), thus
providing a possible environmental hazard. Cad-
mium poisoning has been reported from foods
which had been kept or prepared in cadmium-plated
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containers and has occasionally be found in drink-
ing water in unacceptable levels. Cadmium, in con-
trast to many other elements, accumulates with age
in tissues (3). Very little renal cadmium is present at
birth, but relatively large amounts of this element
are present in kidneys of adults (4), the concentra-
tion in newborn being less than 1% ofadults. Thus,
this pattern is suggestive of environmental expo-
sure.
In our studies, we have investigated the influence
ofcadmium oniron and seleniummetabolism. Since
cadmium has been reported to contribute to hyper-
tension (5, 6), the influence ofthis element onblood
pressures was investigated in rats. A survey was
made on the blood and hair cadmium levels in Ore-
gon residents living in different parts of the state
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FIGURE 1. Effect of dietary cadmium on iron levels in liver and
kidney of rats. Weanling rats (3 male and 3 females/diet) were
fedabasalcaseindiet (11)orthisdietplus2.5,5, 10,25,50, and
100 ppm cadmium for 12 weeks.
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FIGURE 2. Effect of dietary selenium on cadmium levels in liver,
kidneys, and testes. Weanling male rats were fedground Purina
Rat Chow containing 100 ppm cadmium or this diet plus either
2.5, 5.0, or 10 ppm selenium for 8 weeks.
and ofpeople involved in various occupations. Cor-
relations between blood or hair cadmium levels and
hypertension were determined.
As shown in Figure 1, cadmium markedly de-
pressed the iron concentrations in liver and kidney
of rats. A linear decrease occurred up to 50 ppm
after which a plateau was reached. This depression
oftissue ironby cadmium is in agreement with other
work (7-10). Cadmium has been shown to involve
the loss of iron mainly from ferritin (8), which is
consistent with work from my laboratory showing
cadmium to depress iron levels more in the soluble
fraction than other cellular fractions (11).
Selenium will protect against cadmium-induced
testicular damage as discussed by Diplock (12).
Therefore, it was of interest to determine the influ-
ence of selenium on cadmium metabolism. As indi-
, cated in Figure 2, selenium decreased the accumu-
. lation ofcadmium in liver and kidney, butcaused an
E accumulation of this element in the testes. A pro-
e portional increase of cadmium in the testes oc-
' curred with each increase of dietary selenium,
whereas the depression of cadmium in liver and
, kidney by selenium reached a plateau at 5 ppm.
0 The results shown in Figure 3 indicate that
selenium does not counteract or worsen the effect
of cadmium in depressing tissue iron levels. Thus,
the beneficial effects of selenium against cadmium
is by other means.
Selenium was shown to divert the binding of
cadmium in testes cytosols, and this was suggested
as a possible way this element counteracted the
damaging effects of cadmium (13). We extended
these studies to determine whether injected
selenium would divert the binding of injected cad-
mium in other tissues. In addition to the testes,
selenium was found to also divert the binding of
i cadmium in kidney and plasma, but not very much
in the liver (14). Thus, the interaction of selenium
and cadmium is tissue-dependent. An example of
the influence ofselenium on cadmium binding in the
kidney cytosols is shown in Figure 4.
In the reverse situation, cadmium was not found
to have any influence on either the activity of the
a
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FIGURE 3. Effect of dietary selenium and cadmium on liver and
kidney iron content. These are the same rats described in Fig-
ure 2. The data are shown for rats fed 5 ppm selenium in the
diet, but other levels of selenium gave similar responses.
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FIGUR.E 4. Influence ofselenium pretreatment on cadmium binding
to proteins in kidney cytosol. Male rats (200 g) which had been
fed Purina Chow were injected intraperitoneally with 50
tkCiCdl"5 plus 2 mgcadmium perkgbodyweight as the chloride
(upper graph) or with this plus 50 ,uCi 75Se and 1.42 mg
selenium as sodium selenite/kg body weight at another site
(lowergraph). The rats were killed 2 hr afterinjection, and the
kidneys homogenized (I g/2 ml) in 0.05M Tris, pH 8.4. The
cellular components were centrifuged out by differential cen-
trifugation and the cytosol eluted through G-75 Sephadex col-
umns (2 x 90cm) at aflow rate of24 ml/hrwith0.O5MTris, pH
8.4. About 4 ml was collected per fraction.
selenoenzyme, glutathione peroxidase, or on the
tissue selenium content(15). However, cadmiumhas
been shown to alter selenium metabolism (12).
The environmental significance ofthese injection
experiments, however, is questionable, since either
oral dosing ofselenium and cadmium or inclusion in
the diet do not cause a diversion of cadmium bind-
ing in tissues (15). Since animals (and man) are ex-
posed to heavy metals in the environment either
through the oral orpulmonary route, selenium must
counteract metals such as environmental cadmium
by other mechanisms besides diverting theirbinding
in tissue proteins. It should be emphasized that
cadmium-induced testicular damage is brought
about when this element is injected and not when it
is given orally. Thus, the protection by selenium of
testicular damage due to injected cadmium could be
by diverting its binding in this tissue. This accumu-
lation ofcadmium in testes as the result ofselenium
may also suggest that tissue cadmium concentra-
tions alone cannot be used to assess possible tox-
icity under all circumstances.
Metallothionein (MT) is a protein which binds
cadmium (16, 17). Since the binding of metals by
MT has been advocated to be the way it counteracts
heavy metal toxicity, an experiment was conducted
to determine if thionein, the metal free MT, would
prevent the testicular damage due to cadmium.
Thionein (25 mg/kg) was injected intraperitoneally
into rats (200g) 15 min before"0Cd (500ACi/kg) and
cold cadmium (0.01 mmole/kg) injections. Two days
afterwards the rats were killed and the testes exam-
ined for swelling and hemorrhages. However, thio-
nein was not found to protect the testes against
cadmium damage, but caused an unusual distribu-
tion ofcadmium among the tissues. This prompted a
study on the metabolism ofcadmium bound to MT.
Interestingly, about 60% of the dose of cadmium
with MT was deposited in the kidneys (Table 1).
Thus, even though MT was purified from the liver,
the cadmium was deposited predominantly in the
kidneys. In contrast, the livercontained most ofthe
cadmium when a cadmium salt was injected. The
othertissues (blood, heart, spleen, and testes) ofthe
cadmium chloride injected rats also contained more
cadmium than the MT-injected rats. The greater
urinary content ofcadmium in the MT-injected rats
is probably due to this greater deposition in the kid-
neys. This indicates that the "form" of cadmium
has a pronounced effect upon its metabolism. Simi-
Table 1. Comparative metabolism of cadmium chloride or
cadmium bound to thionein.a
Distribution of dose, %b
Tissue 109CdC2 109Cd MTPJ '09Cd MTPJJ
Blood 0.20 t 0.27 0.016 t 0.004 0.004 t 0.003
Heart 0.11 t 0.11 0.013 t 0.003 0.011 t 0.001
Kidneys 1.68 t 0.52 60.4 t 1.51 63.5 t 2.25
Spleen 1.75 t 1.1 0.028 t 0.006 0.037 t 0.004
Testes 0.77 t 0.48 0.064 t 0.014 0.073 t 0.004
Liver 32.45 t 16.7 3.58 t 1.28 2.51 t 0.15
Urine 0.03 t 0.02c 9.89 t 1.5wY 14.0 t 1 94c
Feces 0.162 t 0.033d 0.186 t 0.034d
a All rats were killed 24 hr after injection. Cadmium-thionein
(I mg) was injected intraperitoneally in rats (200 g). The same
amount of cadmium chloride was used to equal the amount of
cadmium in the MT preparations. The cadmium thionein was
purified from livers ofrats which had been fed 100 ppm cadmium
in the diet for 4 weeks and injected with 500 ,Ci '09Cd/kg body
weight 24 hr before they were killed. The cadmium-thionein
species (MTP, and MTP,,) were purified by gel filtration (G-75
Sephadex), ion exchange resin (DEAE cellulose) and hy-
droxylapatite chromatography.
b Percent of dose (means of four rats t standard errors).
c Percent of dose in 24 hr urine.
d Percent of dose/g feces.
February 1979 117Table 2. Effect of dietary ascorbate, citrate, and cysteine on tissue cadmium and iron levels in rats fed diets containing cadmium."
Testis" Liver" Kidney"
Diet Cd, ppm Fe, ppm Cd, ppm Fe. ppm Cd. ppm Fe. ppm
Cadmium 3.2 ± 0.4' 75.3 ± 10.8 8.0 ± 1.4 194.3 + 48.9" 90.7 ± 22.0 20.1 + 7.0d
Cadmium + ascorbate 2.1 ± 0.3" 100.6 ± 15.1 5.1 + 1.4"' 263.8 + 59.5" 73.1 ± 10.9" 37.3 - 5.7'
Cadmium + citrate 3.1 ± 0.8' 72.4 ± 19.1" 14.7 + 6.3' 182.5 ± 48.1"1 109.8 + 22.2 23.7 + 4.8"
Cadmium + cysteine 3.1 ± 0.8' 110.2 ± 12.6 9.0 + 3.6 273.9 + 100.3' 92.6 ± 25.1 36.5 + 9.5'
Cadmium + ascorbate 2.1 ± 0.2"' 97.1 ± 8.4 5.7 + 1.9" 233.8 + 90.3 84.9 + 7.0 31.8 + 9.9
+ citrate
Cadmium + citrate 3.6 ± 0.6' 117.2 ± 37.2 9.5 + 4.3 316.1 + 137.4' 101.8 + 30.0 34.0 + 8.6
+ cysteine
Cadmium + ascorbate 3.2 ± 1.8' 163.5 ± 94.7' 5.5 + 1.7"' 366.3 + 126.9' 84.2 + 8.9 42.8 ± 14.9'
+ cysteine
Cadmium + ascorbate 2.1 ± 0.3" 108.4 ± 20.9 4.7 + 1.8"' 282.6 + 45.4 74.8 + 14.9" 32.7 + 9.1
+ citrate + cysteine
Basal (no additional 0.6 ± 0.2 141.4 ± 10.8 0.2 + 0.01 348.2 ± 45.5 0.3 + 0.01 51.5 + 10.4
Cd)
(I Weanling male rats (6/diet) were fed ground Purina rat chow containing 100 ppm cadmium or this diet plus either single additions or
various combinations of 1% ascorbate, citrate, or cysteine. The rats were fed these diets for 8 weeks.
'} Mean of six determinations ± standard deviation.
c. dValues within a column are significantly different.
lar patterns have been obtained by other workers on
the metabolism of MT (18). However, additional
work needs to be done on the metabolic fate of the
protein moiety.
A few years ago a commercial product containing
cysteine and citrate was marketed and claimed to
decrease the absorption ofheavy metals. Ascorbate
has been shown to decrease the accumulation of
cadmium in tissues and to counteract the anemia
due to this element (19). In light ofthese reports and
the results in Table 1, an experiment was conducted
to study the influence of ascorbate, citrate, or cys-
teine alone or in various combinations on cadmium
accumulation and iron content of tissues. In all tis-
sues, dietary ascorbate either alone or in combina-
tion with citrate resulted in a reduced accumulation
of cadmium in tissues (Table 2). The addition of
cysteine reduced the effectiveness of ascorbate in
reducing cadmium accumulation. Ascorbate ap-
peared to be just as effective alone as compared to
its combination with citrate. In fact, citrate alone
caused an accumulation ofcadmium, particularly in
liver and kidney. A slightly different pattern is ap-
parent for the iron levels. The combination of as-
corbate and cysteine was most effective in causing
iron accumulation. Citrate had the most depressing
effect on the accumulation of iron, but this was
counteracted to a certain extent by ascorbate or
cysteine. Thus, ascorbate alone appears to be most
effective in reducing the concentration ofcadmium,
but this compound plus cysteine are most effective
in causing an accumulation of iron.
Some low-level cadmium exposure experiments
are presently in progress at Oregon State University
(20). Rats were given 1 to 1000 ppb cadmium in
water or food for 1, 2, 4, 8, or 12 weeks, and the
kidney was found to accumulate the highest con-
centration of this element. However, the liver be-
cause of its size contained from 35% to 55% of the
total body burden, while the kidney accounted for
35 to 45% of this burden. No significant difference
was found in the percentage of dose absorbed or
rate of cadmium accumulation when the same con-
centration ofcadmium was provided in food versus
the water. Female rats tended to accumulate cad-
mium at a faster rate and absorb a larger percentage
ofthe ingested dose than did male rats. Differences
in binding of cadmium to the tissue cytosolic pro-
teins were found between tissues from rats fed diets
with low levels ofcadmium (I to 1000 ppb) as com-
pared to those from rats fed a high level ofcadmium
(100 ppm). The results are consistent with the work
ofanother group (21). This indicates that low levels
ofcadmium should be used in order to simulate the
physiological effects ofenvironmental levels ofthis
element.
Since cadmium has been implicated in hyperten-
sion (5, 6), we conducted experiments to investigate
this relationship. However, we found no significant
effects of cadmium on blood pressure when rats
were given cadmium in the water for 88 weeks (Fig.
5). There was an insignificant increase of about 5
mm Hg in the cadmium-fed rats between 22 and 44
weeks of age. Neither did the addition of cadmium
to water for genetically hypertensive rats have any
significant effect on their blood pressures (Fig. 5,
insert). These results are consistent with a number
ofother results (2, 23-27), but in disagreement with
two research groups (5, 6, 22).
The results of various investigators on the influ-
ence of cadmium on blood pressures in rats are
summarized in Table 3. It is evident that the dis-
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FIGURE 5. Influence ofcadmium in the drinking water on the blood
pressure of rats. Insert shows the influence of cadmium in the
water on the blood pressure ofagenetically hypertensive strain
of rats. Data from Whanger (10).
agreement is not due to the strain of rats, the
method ofcadmium administration, or the doses of
cadmium used. Since the two groups of inves-
tigators reporting hypertension due to cadmium
used a rye flour-based diet, whereas those re-
searchers who found negative responses used other
kinds of diets this may be a contributing factor.
Among the dietary factors which may contribute to
this disagreement could be the levels of sodium,
calcium, zinc, copper, or selenium. Thus, if cad-
mium contributes to hypertension, it must cause
this disorder under a very limited set ofconditions,
which raises serious questions concerning its re-
lationship to hypertension in the general environ-
ment.
In order to obtain some information on relation-
ship of blood and hair cadmium levels and hyper-
tension in people, a survey study was conducted
with some Oregon residents. At the time ofdrawing
blood, the name, age, occupation, smoking habits,
water source, years at location, and blood pressure
were obtained from each donor. The cadmium
levels in blood and hair were highest in people living
in the town ofRiddle, Oregon (Table 4). Employees
of the local nickel mines had significantly higher
blood levels than the resident ofthis town or people
living in other locations of the state. Cadmium is a
contaminant of the nickel ore and this is probably
the source of the element for these employees. No
relationship between blood cadmium levels and
blood pressure was found either in the employees of
this mine or in residents ofthe various cities ofOre-
gon. Cadmium analyses on blood from hypertensive
and normotensive patients ofthe Veteran's Admin-
istration Hospital in Portland, Oregon, revealed no
differences between these patients (Table 4). The
higher blood cadmium in these patients is probably
due to their age, since this element is known to
accumulate in tissues of people as they grow older
(3). Thus, blood cadmium levels were not related to
hypertension, and neither were the cadmium levels
of these patients correlated to renin or aldosterone
levels. These data are in agreement with those of
Beevers et al. (28), who found no difference in
blood cadmium levels between normotensive and
hypertensive patients of similar ages.
Schroeder (29) reported cadmium content to be
significantly higher in kidneys, and Glauser et al.
Table 3. Summary of effects of cadmium on hypertension in rats.
Cd
administered, Time, Hyper-
ppm Strain days Diet tension Investigators
0.1-10.0 Long-Evans 182-365 Rye flour based Yes Perry and Erlanger (6)
5.0 Long-Evans 180-240 Rye flour based Yes Schroeder et al. (5, 22)
5.0 Wistar 480 Commercial No Lener and Musil (23)
5.0 Long-Evans 320 Egg white based No Doyle et al. (25)
5.0 Sprague-Dawley 365 Commercial No Friberg et al. (2)
1-30 Wistar 90 Commercial No Loeser and Lorke (26)
10-20 OSU Brown 660 Casein based No Whanger et al. (10)
20 Genetically hypertensive 112 Casein based No Whanger et al. (10)
Injected 2 mg/kg Long-Evans 120 ? Yes Schroeder et al. (22)
Injected, Sprague-Dawley 78-124 Commercial No Porter et al. (24)
0.2-2 mg/kg
Oral dose, Sprague-Dawley 100 Commercial No KatsonisandKlaassen(27)
25-150 mg/kg
February 1979 119Table 4. Cadmium concentrations in blood and hair of some
Oregon residents.
Cd concentrationa
Town Blood, ppb Hair, ppm
Pendleton 3.2 + 0.5 0.73 ± 0.34b
Klamath Falls 5.3 ± 3.8 0.54 ± 0.32b
Eugene 3.8 ± 2.4 1.31 ± 0.42
Portland 6.8 + 4.6e 1.48 ± 0.42e
Coos Bay 5.6 ± 3.0 1.21 ± 0.39c
Riddle 7.8 ± 5.6d 1.83 ± 0.42c
a Means of 8-10 samples ± standard error. b.c Significantly different (p < 0.05).
d Nickel mine employees; 20.0 ± 3.1 ppb (p < 0.05).
e V. A. Hospital (Portland); blood ofhypertensive, 8.9 ± 5.0;
normotensive, 9.0 ± 4.0 ppb.
Table 5. Effects ofoccupation on hair cadmium levels in some
Oregon workers.a
Occupation Hair, ppmb
Metal workers (welders, 1.68 ± 0.44c
sheet metal workers, electroplating, etc.)
Laborers (no metals in occupation) 1.39 ± 0.43
Office workers 0.96 ± 0.39"
a Smokers, 1.66 + 0.45 ppm; nonsmokers, 0.90 ± 0.38 ppm
(p < 0.05).
b Means ± standard error.
c,d Significantly different (p < 0.05).
(30) reported. the cadmium levels to be higher in
blood of hypertensive than normotensive humans.
However, in both ofthese studies the hypertensive
people were about 10 years older than the nor-
motensive ones, and this difference in all probabil-
ity is an age effect. This possibility is supported by
the data ofMorgan (31), who found no difference in
renal cadmium content between control and hyper-
tensive patients of similar ages.
When the blood and hair cadmium data were re-
calculated and comparisons made with respect to
smoking habits or occupations, differences were
also found. The hair cadmium content was highest
in metal workers, intermediate in laborers not using
metals in their occupation, and lowest in office
workers (Table 5). Hair cadmium levels were found
to be higher in smokers than nonsmokers, indicating
this factor must be taken into consideration in
studies of this type. No differences were found in
blood cadmium levels either between smokers and
nonsmokers or between people ofthe various occu-
pations. This blood cadmium pattern of smokers
and nonsmokers, however, is inconsistent with
otherdata (28). These blood levels no doubt depend
upon the smoking patterns ofthe subjects, and this
may be the reason for disagreement.
In conclusion, since cadmium causes a marked
depression in tissue iron levels and ascorbate de-
creases the accumulation of cadmium in tissues, I
would like to propose that people exposed to this
element should elevate their intake of iron and as-
corbate. Although more data are needed, the pres-
ent information would suggest beneficial effects
would be obtained. The data indicate that neither
citrate or cysteine improves the beneficial effect of
ascorbate. Cadmiumaccumulatesintissuesathigher
concentration in animals given cadmium plus
selenium than in those givenjust cadmium, but cad-
miumisless toxic inthefirstgroup. Therefore, more
information is needed to distinguish between tissue
cadmium which is toxic and that which is not toxic.
This suggests that tissue cadmium content alone
cannot be used under all circumstances to assess
toxicity.
Injection experiments need to be confirmed by
those in which the test agent is administered orally
or by the pulmonary route. Different results have
been obtained when administration oftest materials
is by injection compared to ingestion. Since animals
are exposed in the environment by the oral or pul-
monary routes, results must be obtained by these
routes to simulate environmental conditions.
Another point which should be made is that more
low-level long-term experiments need to be con-
ducted. It can no longer be assumed that high expo-
sure for a short term is similar to low exposure over
along term. The difference in binding ofcadmium in
tissues from animals fed 100 ppm cadmium in the
diet for a short period as compared to those fed 1
ppm cadmium in the diet for several months is an
example. Similar patterns have also been noted for
mercury in my laboratory. Therefore, chronic ex-
posure to chemicals at concentrations likely to be
found as the result ofenvironmental contamination
is necessary to simulate the physiological effects
under environmental conditions.
The studies conducted in this laboratory were supported in
part by the U. S. Public Health Service Research Grant Number
ES 00529 from the National Institute of Environmental Health
Sciences.
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